ADVFN - Advanced Financial Network.
HOME» NYSE » B » BCR Stock Price » BCR Stock News

Bard C R Share News

 Bard (c.r.), Inc. Stock Price
BCR Stock Price
 Bard (c.r.), Inc. Stock Chart
BCR Stock Chart
 Bard (c.r.), Inc. Stock News
BCR Stock News
 Bard (c.r.), Inc. Company Information
BCR Company Information
 Bard (c.r.), Inc. Stock Trades
BCR Stock Trades

C.R. Bard 3Q Net Down 1.5% On Charges; Sales Fall Short

DOW JONES NEWSWIRES C.R. Bard Inc.'s (BCR) third-quarter profit fell 1.5% on acquisition and other charges as the medical-products maker reported revenue below analysts' expectations. The company--which makes vascular, urology and oncology devices--had seen profit and sales rebound in recent quarters as health-care spending has rebounded somewhat, although Americans have been cutting back on medical care lately. C.R. Bard posted earnings of $127.5 million, or $1.34 a share, compared with $129.5 million, or $1.31 a share, a year earlier. Shares outstanding fell 4% and the latest quarter included 9 cents of charges. Revenue rose 6.5% to $678.4 million and climbed 8% excluding currency fluctuations. Analysts, on average, expected earnings of $1.40 on revenue of $686.74 million. The company in July gave a mixed third-quarter forecast: earnings of $1.37 to $1.41 on revenue of $688 million to $701 million. Gross margin rose to a record 62.9% from 62.2%, but that was more than offset by overhead costs climbing 13%. The vascular business was Bard's biggest by revenue, and it climbed 13% on a constant currency basis. Similarly sized urology and vascular had lower growth. Shares of C.R. Bard closed Thursday at $85.14 and were inactive after-hours. -By Yogita Patel and Kevin Kingsbury, Dow Jones Newswires; 212-416-2262; yogita.patel@dowjones.com

Stock News for Bard C R (BCR)
DateTimeHeadline
03/26/201503:20:53Top Large Cap Stocks That Investors Can Buy Now
03/25/201509:39:29Statement of Changes in Beneficial Ownership (4)
03/13/201513:21:30Proxy Statement (definitive) (def 14a)
03/07/201500:36:53Ranking The Dividend Champions
03/06/201508:04:35J & J on the hook for $5.7M in California mesh trial
03/04/201512:00:00Bard to Present at Barclays Global Healthcare Conference
03/01/201505:02:23Some Companies Are More Wonderful Than Others
03/01/201504:33:35The Best Scoring Stocks To Buy Now
02/26/201518:22:23Statement of Changes in Beneficial Ownership (4)
02/25/201510:30:00Bard to Present at Raymond James Institutional Investors Conference
02/20/201515:52:13Statement of Changes in Beneficial Ownership (4)
02/20/201515:52:13Statement of Changes in Beneficial Ownership (4)
02/20/201515:51:49Statement of Changes in Beneficial Ownership (4)
02/20/201515:51:49Statement of Changes in Beneficial Ownership (4)
02/20/201515:51:49Statement of Changes in Beneficial Ownership (4)
02/20/201515:51:49Statement of Changes in Beneficial Ownership (4)
02/20/201515:51:49Statement of Changes in Beneficial Ownership (4)
02/19/201517:30:38Statement of Changes in Beneficial Ownership (4)
02/19/201511:52:00CMS Approves Pass-Through Payment for Lutonix DCB for Outpatient...
02/18/201517:49:42Statement of Changes in Beneficial Ownership (4)

Bard C R and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad